Core Insights - Volkswagen has received bids from leading private equity firms such as Blackstone, EQT, and CVC for its Everllence division, indicating strong interest in the asset from major investment players [1] Group 1 - The involvement of top private equity funds suggests a competitive bidding environment for Volkswagen's Everllence division [1] - The Financial Times reported this development, highlighting the significance of the interest from these firms [1]

Core Insights - EQT Corporation reported a revenue of $2.09 billion for the quarter ended December 2025, marking a 15% increase year-over-year and a surprise of +1.47% over the Zacks Consensus Estimate of $2.06 billion [1] - The earnings per share (EPS) for the quarter was $0.90, compared to $0.69 in the same quarter last year, resulting in an EPS surprise of +22.67% against the consensus estimate of $0.73 [1] Financial Performance Metrics - The average natural gas price, including cash settled derivatives, was $3.32, exceeding the average estimate of $3.16 [4] - The average sales price for natural gas was $3.76, compared to the estimated $3.42, while the average sales price for oil was $44.98, slightly below the estimated $45.41 [4] - Total sales volume for natural gas was 572,231.00 MMcf, surpassing the average estimate of 563,644.60 MMcf, and oil sales volume was 585.00 MBBL, exceeding the estimate of 462.98 MBBL [4] - Operating revenues from pipeline and other sources were $170.04 million, above the average estimate of $147.4 million, reflecting a year-over-year change of +1.8% [4] - Operating revenues from the sales of natural gas, natural gas liquids, and oil reached $2.1 billion, compared to the estimated $1.96 billion, representing a +28.2% change year-over-year [4] - Total natural gas and liquids sales, including cash settled derivatives, were $2.09 billion, exceeding the average estimate of $1.92 billion and showing a year-over-year increase of +15% [4] - Natural gas sales, including cash settled derivatives, amounted to $1.9 billion, compared to the average estimate of $1.74 billion [4] Stock Performance - EQT shares have returned +16.2% over the past month, contrasting with a -1.4% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

EQT Reports Fourth Quarter and Full Year 2025 Results and Provides 2026 Guidance PITTSBURGH, February 17, 2026 -- EQT Corporation (NYSE: EQT) today announced financial and operational results for the fourth quarter and full year 2025 as well as financial and operational guidance for 2026. Fourth Quarter Results: Fourth Quarter and Recent Highlights: 2026 Outlook: President and CEO Toby Z. Rice stated, "EQT delivered outstanding performance across the board in 2025, exceeding production forecasts, achieving ...

Core Insights - EQT Corporation reported strong financial and operational results for Q4 and full year 2025, with significant increases in production, cash flow, and reserves, while providing optimistic guidance for 2026 [1][2][3] Financial Performance - Q4 2025 total sales volume reached 609 Bcfe, a slight increase from 605 Bcfe in Q4 2024, with an average realized price of $3.44 per Mcfe, up from $3.01 [1] - Full year 2025 total sales volume was 2,382 Bcfe, compared to 2,228 Bcfe in 2024, with an average realized price of $3.19 per Mcfe, up from $2.74 [2] - Net income attributable to EQT for Q4 2025 was $677 million, compared to $418 million in Q4 2024, and for the full year, it was $2,039 million, significantly up from $231 million in 2024 [1][2] - Free cash flow attributable to EQT for Q4 2025 was $744 million, up from $580 million in Q4 2024, and for the full year, it was $2,503 million, compared to $684 million in 2024 [2] Operational Highlights - Proved reserves increased by 7% year-over-year to 28.0 Tcfe, with a total standardized measure of discounted future net cash flows of $21 billion [1][2] - The company achieved record operational efficiencies, including the fastest quarterly completions pace and the most lateral footage drilled in 24 and 48 hours [1] - Production uptime during Winter Storm Fern was approximately twice as good as peers in Appalachia, demonstrating resilience in challenging conditions [1] 2026 Guidance - The company expects to exit 2026 with approximately $4.7 billion in net debt and projects free cash flow of around $3.5 billion for the year [1][2] - Production forecast for 2026 is set between 2,275 and 2,375 Bcfe, with maintenance capital expenditures estimated at $2,070 to $2,210 million [1][2] - Growth capital expenditures for 2026 are planned at $580 to $640 million, focusing on high-return infrastructure projects [1][2] Strategic Moves - EQT increased its ownership in the Mountain Valley Pipeline (MVP) from approximately 49% to 53% through a $115 million acquisition [1][3] - The company has increased its hedge percentage for 2026 from 7% to 25%, with collars set at average floor and ceiling prices of $3.94 and $5.70 per MMBtu, respectively [1]

Private equity firms EQT and Vitruvian Partners are working with advisers as they explore strategic options for their investment in cyber insurer CFC, according to people familiar with the matter https://t.co/lavpOhRund ...

Core Viewpoint - Goldman Sachs is optimistic about the energy sector, highlighting ten top stocks that offer dividends and significant growth potential, as energy stocks have outperformed the S&P 500 in 2026 due to favorable market conditions [1]. Energy Sector Performance - Energy stocks have surged in 2026, with the XLE index up 23% compared to the S&P 500's 1% increase, driven by high oil prices around $70 per barrel, recovering demand from Asia, and geopolitical tensions [1]. - Goldman Sachs anticipates continued strong performance in the energy sector, with an average total return of approximately 19% for their top picks [1]. Key Stock Recommendations - **Cheniere Energy (LNG)**: Leading U.S. LNG exporter with a 0.94% dividend, positioned for growth in domestic and international markets. Goldman Sachs targets a price of $275, indicating a 25% potential gain [1]. - **EQT Corp (EQT)**: One of the largest U.S. natural gas producers with a 1.14% dividend, focused on low-cost production in the Appalachian Basin. Goldman Sachs sets a price target of $66, suggesting a 16% upside [2]. - **Golar LNG (GLNG)**: Newly added to the Conviction List, offering a 2.26% dividend. Goldman Sachs has a target price of $56, representing a 27% potential gain [2]. - **Viper Energy (VNOM)**: Focused on mineral and royalty interests in the Permian Basin, with a 5.39% dividend yield. Goldman Sachs targets a price of $54, indicating a 23% upside [2]. - **Vistra Corp (VST)**: An integrated electricity and power generation company with a 0.56% dividend, expected to support data centers and cloud computing. Goldman Sachs sets a price target of $205, representing a 28% potential gain [2].

Market Overview - The public market for 2026 appeared stable until recent advancements in enterprise AI raised concerns among investors regarding the software-as-a-service (SaaS) industry's assumptions [2][3] - A significant selloff occurred, with notable declines in major SaaS companies: Salesforce down over 3%, Adobe down 3%, Docusign down 5.5%, and Workday down more than 10% over five days [3] Industry Concerns - The term "SaaSpocalypse" has emerged, highlighting the uncertainty in the SaaS sector as the industry lacks a clear strategy for monetizing enterprise AI [3] - Experts suggest that the traditional reliance on software execution as a competitive advantage is diminishing, as the cost of software development approaches zero [4] Future Implications - The long-term impact of AI on SaaS revenue is uncertain, with potential losses amounting to hundreds of billions or even trillions of dollars [5] - The prevailing sentiment indicates that the current market reaction may be exaggerated, but the fundamental question remains whether AI will significantly disrupt SaaS [5] Venture Capital Activity - Anthropic raised $30 billion in Series G funding, indicating strong investor interest in AI companies [7] - Other notable funding rounds include Talkiatry with $210 million in Series D funding and Simile with $100 million, reflecting ongoing investment in AI and related technologies [8]

RT Lisa Du (@lisadont)Our story on PE giants like Blackstone, KKR, EQT's attempt to tap Japan's wealthy retail investors for funds as institutional money wanes. Most see Japan as the largest private wealth opportunity outside of the US, but the market comes with its challenges: https://t.co/7ZpfR0iWyB ...

Group 1 - Platinum Equity has agreed to sell Urbaser, a Spanish waste management company, to Blackstone and EQT for $6.6 billion [1] - Platinum Equity will retain ownership of Urbaser's waste management business in Argentina [1]

Company Overview - Encube Ethicals, founded in 1998 by Mehul Shah, is a pharmaceutical contract development and manufacturing organization (CDMO) focused on topical formulations, including well-known brands like Soframycin [5][12] - The company operates three manufacturing facilities located in Goa and Indore, serving customers in India and the US, and has secured regulatory approvals from 12 overseas authorities, including the US FDA [6][12] Investment and Valuation - A consortium of Warburg Pincus and Mubadala is set to acquire a majority stake of up to 74% in Encube Ethicals, valuing the company at approximately Rs 16,500 crore ($1.8 billion), which translates to about 24 times its projected FY26 EBITDA [1][12] - The financial investors are expected to fully exit, while the promoter group will dilute their stake to 15-20%, becoming a junior partner [3][13] Financial Performance and Projections - Encube Ethicals has experienced significant growth, with sales expected to reach Rs 4,000 crore in the next three years, up from Rs 500 crore in 2021, and projected FY26 revenue at Rs 1,880 crore [8][12] - The company aims for a 30% EBITDA margin in FY27, with its CDMO unit accounting for nearly half of its business [8][9] Market Dynamics - The demand for scaled CDMO businesses is strong, driven by global supply chain diversification away from China and the positive long-term impact of the US BioSecure Act [1][12] - Encube has filed for abbreviated new drug applications (ANDAs) in the US for several new products, which is expected to contribute over Rs 800 crore to its topline [9][12] Strategic Intent - Encube intends to expand into complex products in gynecology and dermatology, areas that have historically been challenging for even large pharmaceutical companies [10][12] - The management is optimistic about signing a share purchase agreement within the next two to three weeks, indicating a proactive approach to the acquisition process [5][12]